IP Library › Granted Patent US 12,721,516
Granted Patent B2
US 12,721,516 · App. 18/475,372 · Granted Sep 1, 2026

Vitreous floater characterization using aberrometry

Inventor: Paul R. Hallen (Colleyville, TX)
Assignee: Alcon Inc.
A61B3/1015A61B3/0025A61B3/102A61B3/103G01S17/894G06T7/0016A61B2560/02A61B2560/04G06T2207/30041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,516
App. No.
18/475,372
Granted
Sep 1, 2026
Kind
B2
Abstract

Particular embodiments include, by a computing device, receiving one or more wavefront elevation maps for a patient's eye and identifying one or more attributes of the one or more wavefront elevation maps corresponding to vitreous floaters. The one or more attributes may include localized spatial variation of the one or more wavefront elevation maps; temporal variation among a plurality of wavefront elevation maps; and depth information indicating scattering of light from within the vitreous of the patient's eye. A machine learning model may be trained and utilized to characterize vitreous floaters based on the one or more wavefront elevation maps and other patient data. The wavefront elevation maps may be measured using an aberrometer. The aberrometer may be integrated with a LIDAR system to estimate depth of scattered light. A common laser light source may be used for both the aberrometer and the LIDAR system.

Claims (30)

1 . An ophthalmic system for guiding ophthalmic surgery comprising:

an aberrometer;

one or more processing devices;

one or more memory devices coupled to the one or more processing devices and storing executable code that, when executed by the one or more processing devices, causes the one or more processing devices to:

receive one or more wavefront elevation maps for a patient's eye from the aberrometer; and

identify one or more attributes of the one or more wavefront elevation maps corresponding to vitreous floaters;

wherein the one or more wavefront elevation maps comprise a plurality of wavefront elevation maps captured at different times and the one or more attributes include temporal variation among the plurality of wavefront elevation maps.

2 . The ophthalmic system of claim 1 , wherein the one or more attributes include localized spatial variation of the one or more wavefront elevation maps.

3 . The ophthalmic system of claim 1 , wherein the one or more wavefront elevation maps comprise the plurality of wavefront elevation maps captured at different times and the one or more attributes include temporal variation among the plurality of wavefront elevation maps and localized spatial variation of the plurality of wavefront elevation maps.

4 . The ophthalmic system of claim 1 , wherein the aberrometer is an Optiwave Refractive Analysis (ORA) system.

5 . The ophthalmic system of claim 1 , further comprising:

a light distancing and ranging (LIDAR) system combined with the aberrometer and configured to capture depth information simultaneously with the one or more wavefront elevation maps;

wherein the one or more attributes include the depth information.

6 . The ophthalmic system of claim 5 , wherein the one or more attributes include whether the depth information indicates scattering within a vitreous of the patient's eye.

7 . The ophthalmic system of claim 5 , wherein the aberrometer and the LIDAR system have a common laser light source and a common scanning mirror.

8 . The ophthalmic system of claim 1 , wherein the executable code that, when executed by the one or more processing devices, further causes the one or more processing devices to identify the one or more attributes of the one or more wavefront elevation maps corresponding to the vitreous floaters by processing the one or more wavefront elevation maps with a machine learning model.

9 . A method for characterizing vitreous floaters comprising:

measuring, by an aberrometer, a patient's eye to obtain one or more wavefront elevation maps;

receiving, by a computing device, the one or more wavefront elevation maps; and

identifying, by the computing device, one or more attributes of the one or more wavefront elevation maps corresponding to vitreous floaters;

wherein the one or more wavefront elevation maps comprise a plurality of wavefront elevation maps captured at different times and the one or more attributes include temporal variation among the plurality of wavefront elevation maps.

10 . The method of claim 9 , wherein the one or more attributes include localized spatial variation of the one or more wavefront elevation maps.

11 . The method of claim 9 , wherein the one or more wavefront elevation maps comprise the plurality of wavefront elevation maps captured at different times and the one or more attributes include temporal variation among the plurality of wavefront elevation maps and localized spatial variation of the plurality of wavefront elevation maps.

12 . The method of claim 9 , wherein the aberrometer is an Optiwave Refractive Analysis (ORA) system.

13 . The method of claim 9 , wherein:

a light distancing and ranging (LIDAR) system is combined with the aberrometer and is configured to capture depth information simultaneously with the one or more wavefront elevation maps; and

the one or more attributes include the depth information.

14 . The method of claim 13 , wherein the one or more attributes include whether the depth information indicates scattering within a vitreous of the patient's eye.

15 . The method of claim 13 , wherein the aberrometer and the LIDAR system have a common laser light source and a common scanning mirror.

16 . The method of claim 9 , wherein identifying the one or more attributes of the one or more wavefront elevation maps corresponding to the vitreous floaters comprises processing the one or more wavefront elevation maps with a machine learning model.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2024
From: ALCON VISION, LLC
To: ALCON INC.
Reel/Frame 066994/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2024
From: HALLEN, PAUL R.
To: ALCON VISION, LLC
Reel/Frame 066994/0430 →
Continuity (2)
Provisional Application 63377223 · Sep 27, 2022
Related Publication 20240099576A1 · Mar 28, 2024
References Cited (209)
US 3780979A · De Guillebon · 1973 [cited by applicant]
US 4357088A · Pomerantzeff · 1982 [cited by applicant]
US 5312396A · Feld · 1994 [cited by applicant]
US 5909270A · Moser · 1999 [cited by applicant]
US 6142630A · Koester · 2000 [cited by applicant]
US 6322556B1 · Gwon · 2001 [cited by applicant]
US 6789900B2 · Van De Velde · 2004 [cited by applicant]
US 7374287B2 · Van De Velde · 2008 [cited by applicant]
US 7510282B2 · Ueno · 2009 [cited by applicant]
US 7520613B2 · Saito et al. · 2009 [cited by applicant]
US 7703922B2 · Van De Velde · 2010 [cited by applicant]
US 8480659B2 · Frey et al. · 2013 [cited by applicant]
US 8652602B1 · Dolla · 2014 [cited by applicant]
US 8783868B2 · Qiu · 2014 [cited by applicant]
US 8876808B2 · Feklistov et al. · 2014 [cited by applicant]
US 8994753B2 · Nakano · 2015 [cited by applicant]
US 9033500B2 · Utsunomiya · 2015 [cited by applicant]
US 9603519B2 · Bor et al. · 2017 [cited by applicant]
US 9675243B2 · Sasak et al. · 2017 [cited by applicant]
US 9789002B2 · Van De Velde · 2017 [cited by applicant]
US 10130511B2 · Dantus · 2018 [cited by applicant]
US 10478342B2 · Dick · 2019 [cited by applicant]
US 10555835B2 · Schuele et al. · 2020 [cited by applicant]
US 20070258094A1 · Izatt et al. · 2007 [cited by applicant]
US 20070291277A1 · Everett · 2007 [cited by applicant]
US 20090073384A1 · Warden · 2009 [cited by applicant]
US 20090137989A1 · Kataoka · 2009 [cited by applicant]
US 20090196477A1 · Cense et al. · 2009 [cited by applicant]
US 20100123873A1 · Raymond · 2010 [cited by applicant]
US 20100152847A1 · Padrick · 2010 [cited by applicant]
US 20110077557A1 · Wing et al. · 2011 [cited by applicant]
US 20120281235A1 · Murata · 2012 [cited by applicant]
US 20130131652A1 · Dick · 2013 [cited by applicant]
US 20130173029A1 · Caldeira et al. · 2013 [cited by applicant]
US 20140058367A1 · Dantus · 2014 [cited by applicant]
US 20140216468A1 · Goldshleger · 2014 [cited by applicant]
US 20140257257A1 · Grant et al. · 2014 [cited by applicant]
US 20140268036A1 · Ketterling et al. · 2014 [cited by applicant]
US 20140276674A1 · Lee · 2014 [cited by applicant]
US 20150190278A1 · Gooding · 2015 [cited by applicant]
US 20150342782A1 · Mordaunt · 2015 [cited by applicant]
US 20160058617A1 · Luttrull et al. · 2016 [cited by applicant]
US 20160074214A1 · Palanker et al. · 2016 [cited by applicant]
US 20160074221A1 · Tassignon et al. · 2016 [cited by applicant]
US 20160166431A1 · Vogler et al. · 2016 [cited by applicant]
US 20160227999A1 · An et al. · 2016 [cited by applicant]
US 20160235588A1 · Hart et al. · 2016 [cited by applicant]
US 20160256324A1 · Suzuki · 2016 [cited by applicant]
US 20160278629A1 · Schuele · 2016 [cited by applicant]
US 20160302969A1 · Yamamoto · 2016 [cited by applicant]
US 20170181625A1 · Kawakami et al. · 2017 [cited by applicant]
US 20170252213A1 · Furuuchi et al. · 2017 [cited by applicant]
US 20170326003A1 · Schuele et al. · 2017 [cited by applicant]
US 20180028354A1 · Heeren · 2018 [cited by applicant]
US 20180028355A1 · Raksi · 2018 [cited by applicant]
US 20180140257A1 · Govindjee et al. · 2018 [cited by applicant]
US 20180206719A1 · Adler et al. · 2018 [cited by applicant]
US 20180317767A1 · Ryan · 2018 [cited by applicant]
US 20180353064A1 · Soetikno et al. · 2018 [cited by applicant]
US 20180368915A1 · Xia et al. · 2018 [cited by applicant]
US 20190076242A1 · Pinto · 2019 [cited by examiner]
US 20190127034A1 · Larson · 2019 [cited by examiner]
US 20190159933A1 · Romano et al. · 2019 [cited by applicant]
US 20190282403A1 · Barrett et al. · 2019 [cited by applicant]
US 20190290124A1 · Laforest et al. · 2019 [cited by applicant]
US 20190313903A1 · Mckinnon · 2019 [cited by applicant]
US 20190365569A1 · Skovgaard · 2019 [cited by applicant]
US 20200038241A1 · Wang et al. · 2020 [cited by applicant]
US 20200060873A1 · Heeren · 2020 [cited by applicant]
US 20200085292A1 · Fukuma et al. · 2020 [cited by applicant]
US 20200129336A1 · Schuele et al. · 2020 [cited by applicant]
US 20200130103A1 · Choi · 2020 [cited by applicant]
US 20200192080A1 · Karam · 2020 [cited by applicant]
US 20200196853A1 · Van Hemert et al. · 2020 [cited by applicant]
US 20200273218A1 · Camino · 2020 [cited by examiner]
US 20200397289A1 · Ralston · 2020 [cited by applicant]
US 20200400422A1 · Ralston · 2020 [cited by applicant]
US 20210100450A1 · Amma · 2021 [cited by applicant]
US 20210186753A1 · Al-Qaisi et al. · 2021 [cited by applicant]
US 20210275009A1 · Yates · 2021 [cited by applicant]
US 20210378507A1 · Wallace · 2021 [cited by applicant]
US 20210386586A1 · Bor · 2021 [cited by applicant]
US 20220012459A1 · Schwiegerling · 2022 [cited by applicant]
US 20220031511A1 · Charles · 2022 [cited by applicant]
US 20220225874A1 · Nekrassov · 2022 [cited by examiner]
US 20230157889A1 · Bor · 2023 [cited by applicant]
US 20230301511A1 · Tsukada · 2023 [cited by examiner]
AU 2018274939B2 · 2020 [cited by applicant]
CN 210009227U · 2020 [cited by applicant]
CN 108371542B · 2020 [cited by applicant]
CN 109196333B · 2020 [cited by applicant]
CN 111281651B · 2020 [cited by applicant]
CN 112862782A · 2021 [cited by applicant]
CN 112587302B · 2021 [cited by applicant]
CN 112587304B · 2021 [cited by applicant]
DE 19705044A1 · 1998 [cited by applicant]
DE 102019007147A1 · 2021 [cited by applicant]
DE 102019007148A1 · 2021 [cited by applicant]
EP 0770370A2 · 1997 [cited by applicant]
EP 1212022B1 · 2005 [cited by applicant]
EP 1563785A1 · 2005 [cited by applicant]
EP 1638452B1 · 2006 [cited by applicant]
EP 1838212A1 · 2007 [cited by applicant]
EP 2144552A1 · 2010 [cited by applicant]
EP 1928297B1 · 2010 [cited by applicant]
EP 2459138A2 · 2012 [cited by applicant]
EP 2525706A2 · 2012 [cited by applicant]
EP 2898820A1 · 2015 [cited by applicant]
EP 3061429A1 · 2016 [cited by applicant]
EP 2890340B1 · 2017 [cited by applicant]
EP 3459487A1 · 2019 [cited by applicant]
EP 3501463A1 · 2019 [cited by applicant]
EP 3636137A1 · 2020 [cited by applicant]
EP 3861924A1 · 2021 [cited by applicant]
GB 2469249A · 2010 [cited by applicant]
JP 5767014B2 · 2015 [cited by applicant]
JP 2017176558A · 2017 [cited by applicant]
JP 6410468B2 · 2018 [cited by applicant]
JP 2018196821A · 2018 [cited by applicant]
JP 2018196822A · 2018 [cited by applicant]
JP 2020022569A · 2020 [cited by applicant]
JP 6736304B2 · 2020 [cited by applicant]
JP 6839902B2 · 2021 [cited by applicant]
RU 2661016C1 · 2018 [cited by applicant]
RU 2692666C1 · 2019 [cited by applicant]
RU 2695629C1 · 2019 [cited by applicant]
RU 2710058C2 · 2019 [cited by applicant]
RU 2726468C1 · 2020 [cited by applicant]
WO 9958047A1 · 1999 [cited by applicant]
WO 0137769A1 · 2001 [cited by applicant]
WO 0195791A1 · 2001 [cited by applicant]
WO 2007059189A2 · 2007 [cited by applicant]
WO 2009033110A2 · 2009 [cited by applicant]
WO 2009036104A2 · 2009 [cited by applicant]
WO 2009039315A2 · 2009 [cited by applicant]
WO 2009059400A1 · 2009 [cited by applicant]
WO 2010117386A1 · 2010 [cited by applicant]
WO 2014053824A1 · 2014 [cited by applicant]
WO 2015131135A1 · 2015 [cited by applicant]
WO 2015171793A1 · 2015 [cited by applicant]
WO 2016033590A1 · 2016 [cited by applicant]
WO 2017062673A1 · 2017 [cited by applicant]
WO 2017196306A1 · 2017 [cited by applicant]
WO 2017205857A1 · 2017 [cited by applicant]
WO 2020074532A1 · 2020 [cited by applicant]
WO 2020180729A1 · 2020 [cited by applicant]
WO 2020215359A1 · 2020 [cited by applicant]
WO 2020216763A1 · 2020 [cited by applicant]
WO 2020257711A1 · 2020 [cited by applicant]
WO 2021023799A1 · 2021 [cited by applicant]
WO 2021049243A1 · 2021 [cited by applicant]
WO 2021066047A1 · 2021 [cited by applicant]
WO 2021092211A1 · 2021 [cited by applicant]
WO 2021183637A1 · 2021 [cited by applicant]
WO 2022149028A1 · 2022 [cited by applicant]
WO 2023089416A1 · 2023 [cited by applicant]
WO 2023089459A1 · 2023 [cited by applicant]
WO 2023097391A1 · 2023 [cited by applicant]
Adrian G.H. Podoleanu et al., Combined optical coherence tomograph and scanning laser ophthalmoscope mi nije dostupan besplatno., Electronics Letters, 34 (11), 1998. [cited by applicant]
Chi-Hung Lee, et al., Imaging vitreous floaters and cataracts with optical simulations, Optik, 194, 1-9, 2019. [cited by applicant]
Christy K. Sheehy et al., High-speed, image-based eye tracking with a scanning laser ophthalmoscope, Biomedical Optics Express, vol. 3, No. 10, 2012. [cited by applicant]
D. H. Kelly, “Retinal Inhomogeneity. II. Spatial Summation,” J. Opt. Soc. Am., pp. 114-119, vol. 1, No. 1 (Jan. 1984). [cited by applicant]
D. H. Kelly, “Retinal Inhomogeneity. III. Circular-Retina Theory,” D.H. Kelly, J. Opt. Soc. Am., pp. 810-819, vol. 2, No. 6 (Jun. 1985). [cited by applicant]
D.H. Kelly, “Visual Processing of Moving Stimuli,” J. Opt. Soc. Am., pp. 216-225, vol. 2, No. 2 (Feb. 1985). [cited by applicant]
D.H. Kelly,, “Motion and Vision. II. Stabilized Spatio-Temporal Threshold Surface,” J. Opt. Soc. Am., pp. 1340-1349, vol. 69, No. 10 (Oct. 1979). [cited by applicant]
D.H.Kelly, “Retinal Inhomogeneity. I. Spatiotemporal Contrast Sensitivity,” J. Opt. Sec. Am., pp. 107-113, vol. 1, No. 1 (Jan. 1984). [cited by applicant]
Mojana F. et al.. Observations by spectral-domain optical coherence tomography combined with simultaneous scanning laser ophthalmoscopy: imaging of the vitreous, American Journal of Ophthalmol. Apr. 2010; 149(4):641-650. [cited by applicant]
Nidek, Scanning Laser Ophthalmoscope Mirante SLO/OCT Mirante SLO, https://www.nidek-intl.com/product/ophthaloptom/diagnostic/dia_retina/mirante.htm. [cited by applicant]
Peter G. J. Barten, “Contrast Sensitivity of the Human Eye and its Effects on Image Quality,” Chapter 3, pp. 27-40, Model for the spatial contrast sensitivity of the eye, (1999). [cited by applicant]
Pointer, J. S., & Hess, R. F. “The contrast sensitivity gradient across the human visual field: With emphasis on the low spatial frequency range,”, R. F. Vision Research, 29(9), 1133-1151 (1989). [cited by applicant]
Sebag J et al., Vitreous and Vitreoretinal Interface, Ch. 21, 2015. [cited by applicant]
Sebag J., Vitreous and Vision Degrading Myodesopsia. Progress in Retinal and Eye Research Nov. 2020;79. [cited by applicant]
T Ivanova et al, Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review, Eye (Lond) May 2016; 30(5):645-55. [cited by applicant]
Teri T Kleinberg et al., Vitreous substitutes: a comprehensive review, Survey of Ophthalmology, 56 (4), 2011. [cited by applicant]
Blake F. Webb, et al.; “Prevalence of vitreous floaters in a community sample of smartphone users”; International Journal of Ophthalmology; Jun. 18, 2013; pp. 402-405; 6(3); PMC/ US National Library of Medicine National… [cited by applicant]
Chirag P. Shah, et al., YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters a Randomized Clinical Trial, JAMA Ophthalmology, Sep. 2017, 918-923, 135-9. [cited by applicant]
Damodaran et al., “Digital micromirror device based ophthalmoscope with concentric circle scanning”, vol. 8, No. 5, pp. 2766-2780, 2017, Biomedical Optics Express. [cited by applicant]
Ellex Website, Treatment Guidelines—Laser Floater Removal; 2016, Ellex Medical Pty Ltd. E&OE. VB0002E, downloaded Apr. 20, 2017. [cited by applicant]
Felix Sauvage et al.: “Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles”, ACS Nano, vol. 13, No. 7, Jul. 9, 2019, pp. 8401-8416. [cited by applicant]
Fischer et al., “Scanning Laser Ophthalmoscopy (SLO)”, In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet], accessed on Jan. 30, 2023 from https:/… [cited by applicant]
Ginner et al., “Wide-Field OCT Angiography at 400 KHz Utilizing Spectral Splitting”, Photonics, vol. 1, No. 4, pp. 369-379, Oct. 23, 2014. [cited by applicant]
Heidelberg Engineering GMBH, “Spectralis. Hardware Operating Instructions,” Version 001, Aug. 2007. [cited by applicant]
Heidelberg Engineering, “Spectralis. Multimodal Imaging Platform Optimized for the Posterior Segment”, accessed on Jan. 30, 2023 from https://business-lounge.heidelbergengineering.com/us/en/products/spectralis/spectrali… [cited by applicant]
Hofer et al., “Dispersion encoded full range frequency domain optical coherence tomography”, vol. 17, No. 1, pp. 7-24, Jan. 5, 2009, Optics Express, US. [cited by applicant]
Hofer et al., “Fast dispersion encoded full range optical coherence tomography for retinal imaging at 800 nm and 1060 nm”, vol. 18, No. 5, pp. 4898-4919, Mar. 1, 2010, Optics Express. [cited by applicant]
Kim Jihwan et al. “Nonmechanical Laser Beam Steering Based on Polymer Polarization Gratings: Design Optimization and Demonstration”, Journal of Lightwave Technology, vol. 33, No. 10, pp. 2068-2077, May 15, 2015. [cited by applicant]
Leitgeb et al., “Complex ambiguity-free Fourier domain optical coherence tomography through transverse scanning”, vol. 32, pp. 3453-3455, 2007, Optics Letters. [cited by applicant]
Li et al., “DMD-based three-dimensional chromatic confocal microscopy”, vol. 59, No. 14, pp. 4349-4356, 2020, Applied Optics. [cited by applicant]
Martial et al., “Programmable Illumination and High-Speed, Multi-Wavelength, Confocal Microscopy Using a Digital Micromirror”, vol. 7, No. 8, e43942, Aug. 2012, PLOS ONE. [cited by applicant]
Michael J. Escuti, et al., “Geometric-Phase Holograms”, Optics & Photonics News, pp. 22-29, Feb. 2016. [cited by applicant]
Milston Rebecca et al: “Vitreous floaters: Etiology, diagnostics, and management”, Survey of Ophthalmology, vol. 61, No. 2, Mar. 1, 2016, pp. 211-227. [cited by applicant]
Nicusor Iftimia et al: “Hybrid retinal imaginer using line-scanning laser ophthalmoscopy and spectral domain optical coherence tomography”, Optics Express, vol. 14, No. 26, Dec. 22, 2006. [cited by applicant]
Reece Bergstrom, et al., Vitreous Floaters, National Center for Biotechnology Information, May 21, 2020, 4 pages, Bookshelf ID NBK470420, StatPearls Publishing LLC, online. [cited by applicant]
Reznicek Lukas et al., “Wide-Field Megahertz OCT Imaging of Patients with Diabetic Retinopathy”, Journal of Diabetes Research, 2015, 5 pages. [cited by applicant]
Ruggeri et al., “Imaging and full-length biometry of the eye during accommodation using spectral domain OCT with an optical switch”, vol. 3, No. 7, pp. 1506-1520, Jul. 1, 2012, Biomedical Optics Express. [cited by applicant]
Sarunic et al., “Instantaneous complex conjugate resolved spectral domain and swept-source OCT using 3x3 fiber couplers”, vol. 13, No. 3, pp. 957-967, Feb. 2005, Optics Express. [cited by applicant]
Shields et al., “Wide-angle Imaging of the Ocular Fundus”, Review of the Ophthalmology, Feb. 15, 2003. [cited by applicant]
Singh, “Lasers Take Aim at Floaters”, Ophthalmology Management, vol. 23, pp. 38, 40-42, 59, Jul. 1, 2019. [cited by applicant]
Singh, “Modern vitreolysis—YAG laser treatment now a real solution for the treatment of symptomatic floaters”, Survey of Ophthalmology, vol. 65, No. 5, pp. 581-591, Mar. 3, 2020. [cited by applicant]
SunLED, NanoPoint-0201 Series LEDs, published Feb. 15, 2016, www.SunLEDusa.com. [cited by applicant]
Volk Optical, “Volk Idrees Mid-Vitreous Lens”, accessed on Dec. 20, 2020 from https://www.volk.com/...s?pr_prod_strat=collection_fallback&pr_rec_pid=4513049018402&pr_ref_pid=4513048952866&pr_seq=uniform, Dec… [cited by applicant]
Volk Optical, “Volk Singh Mid-Vitreous Lens”, accessed on Dec. 20, 2020 from https://www.volk.com/products/singh-mid-vitreous-vitreous-slit-lamp-lens?_pos=3&_sid=b50c0674f&_ss=r, Dec. 20, 2020. [cited by applicant]
Wang et al., “In vivo full range complex Fourier domain optical coherence tomography”, vol. 90, 054103, Jan. 30, 2007, Applied Physics Letters. [cited by applicant]
Wikipedia Encyclopedia, Floater, Wikipedia Encyclopedia, Mar. 29, 2021, online: https://en.wikipedia.org/wiki/rloater?wprov=sfti 1. [cited by applicant]
Wojtkowski et al., “Full range complex spectral optical coherence tomography technique in eye imaging”, vol. 27, No. 16, pp. 1415-1417, 2002, Optics Letters. [cited by applicant]
Yasuno et al., “Simultaneous B—M-mode scanning method for real-time full-range Fourier domain optical coherence tomography”, vol. 45, No. 8, pp. 1861-1865, 2006, Applied Optics. [cited by applicant]
Zhang et al., Removal of a mirror image and enhancement of the signal-to-noise ratio in Fourier-domain optical coherence tomography using an electro-optic phase modulator, vol. 30, No. 2, Jan. 15, 2005, Optics Letters. [cited by applicant]
Zhang Yunbo et al: “Parallel large-range scanning confocal microscope based on a digital micromirror device”, Optik vol. 124, No. 13 (2013), Aug. 4, 2012, pp. 1585-1588. [cited by applicant]
Zhou et al., “Dual channel dual focus optical coherence tomography for imaging accommodation of the eye”, vol. 17, No. 11, pp. 8947-8955, May 25, 2009, Optics Express. [cited by applicant]